Clinical Trial Update: Drug Study of Albuterol to Treat Acute Lung Injury [Phase 2, Phase 3]

View source ↗

Summary

An NHLBI-sponsored Phase 2/Phase 3 trial evaluating albuterol for acute lung injury/acute respiratory distress syndrome was terminated, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Albuterol (albuterol)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Respiratory Distress Syndrome, Adult | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2013-07-15